Figure 2.
siRNA knockdown of PERK has no effect on VEEV replication in U87MG or 293T cells. U87MG cells were transfected with 100 nM of siNeg or siPERK siRNAs. At 48 h post transfection, cells were mock infected or infected with VEEV TC-83 (MOI 5). (A) Viral replication was analyzed via plaque assays using supernatants collected from U87MG cells at 16 hpi. N = 3, ns = not significant. (B) Cell lysates were collected at 16 hpi and analyzed by immunoblot. PVDF membranes were probed for levels of PERK, VEEV GP, and VEEV capsid. β-Actin was used as a loading control. (C,D) Data show the quantitation of the respective immunoblots. Protein levels expressed in each blot were normalized to β-actin and normalized values were calculated relative to siNeg-transfected cells. N = 3, *** p ≤ 0.001. (E) 293T cells were transfected with 100 nM of siNeg or siPERK siRNAs. At 48 h post transfection, cell lysates were collected and analyzed by immunoblot. PVDF membranes were probed for levels of PERK. β-Actin was used as a loading control. (F) 293T cells were transfected with 100 nM of siNeg or siPERK siRNAs. At 48 h post transfection, cells were infected with VEEV TC-83 (MOI 5). Viral replication was analyzed via plaque assays using supernatants collected at 18 hpi. N = 3, ns = not significant.